A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

NCT02915159 PHASE3 COMPLETED Results posted

The purpose of this study is to evaluate the efficacy of abatacept compared to placebo in patients with Sjögren's Syndrome.

Details

Lead sponsor	Bristol-Myers Squibb
Phase	PHASE3
Status	COMPLETED
Enrolment	250
Start date	Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Sjogrens Disease

Interventions

• Abatacept
• Placebo

Countries

France, Italy, Japan, Sweden, Germany, Mexico, South Korea, Argentina, Puerto Rico, Australia, United States, Brazil, Czechia